Kelonia is developing technology to reprogram patients’ T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.
Source: US Top News and Analysis
Related Posts
Dow futures jump over 1,000 points, oil tumbles after Trump suspends Iran attacks for two weeks: Live updates
Trump noted that the “double sided” ceasefire was contingent on Iran agreeing to an opening…
This retail name is in the midst of a recovery story. How to trade it with options
Tony Zhang breaks down this call options vertical spread. Source: US Top News and Analysis
UK ‘not supporting’ U.S. Iran blockade as France’s Macron confirms ‘multinational’ talks on the Strait of Hormuz
President Donald Trump had signaled that other countries would help the U.S. in its blockade.…